Anlon Healthcare Limited has informed the Exchange regarding 'Disclosure dated November 28, 2025, and February 27, 2026, regarding acquisition of stake in Bizotic Life Science Private Limited'.
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anlon Healthcare Limited has completed the acquisition of a 56.67% equity stake in Bizotic Life Science Private Limited on March 20, 2026. This was done under a Share Purchase Agreement originally signed on November 28, 2025, and later amended on February 27, 2026, which extended the completion deadline to April 2, 2026. With this acquisition, Bizotic Life Science has become a subsidiary of Anlon Healthcare. The investment is in compliance with the applicable provisions of the Companies Act, 2013. Further transaction details were already disclosed in the earlier filing dated November 28, 2025.
Bizotic Life Science is now a subsidiary of Anlon Healthcare, expanding the company's portfolio and giving it controlling interest in the target's operations. Shareholders should expect consolidation of Bizotic's financials into Anlon's results going forward.